Risk Regulation in the Single Market: The Governance of Pharmaceuticals and Foodstuffs in the European Union

ISBN-13: 9781349359363 / Angielski / Miękka / 2008 / 225 str.

S. Krapohl

Opis

This book demonstrates how the Thalidomide catastrophe of the 1960s and the BSE crisis of the 1990s led to regulatory regimes for pharmaceuticals and foodstuffs in Europe. However, the developmental paths of these regimes differ and so does the efficiency and legitimacy of regulatory policy-making."

Spis treści

Introduction: The Need for a Systematic Analysis of Supranational Risk Regulation PART I: AN INSTITUTIONALIST APPROACH TO SUPRANATIONAL RISK REGULATION Functional Pressure and Path-Dependencies: The Emergence and Development of Supranational Regulatory Regimes Efficiency and Legitimacy: The Evaluation of Supranational Regulatory Regimes PART II: THE AUTHORIZATION OF PHARMACEUTICALS IN THE EU From National Crises to a Strong Supranational Regime: The Development of Pharmaceutical Authorization in Europe A Strong Regulatory Network: The Evaluation of the European Regulatory Regime for Pharmaceuticals PART III: THE REGULATION OF FOODSTUFFS IN THE EU From an Early Single Market to a Crisis of Consumer Confidence: The Development of Foodstuff Regulation in Europe A Weak Supranational Agency: The Evaluation of the European Regulatory Regime for Foodstuffs PART IV: CONCLUSION A Comparison of Pharmaceutical and Foodstuff Regulation in Europe

O autorze

SEBASTIAN KRAPOHL is Assistant Professor of International Relations and European Politics at the Otto-Friedrich-University of Bamberg, Germany. His research interests include EU politics, risk regulation and regional integration within and outside Europe. Sebastian Krapohl has published articles in the Journal of European Public Policy, the European Law Journal and the European Journal of Political Research.